Skip to main content

Biopharma Startups

Updated July 2026

Companies in the biopharma sector developing innovative solutions and technologies.

Explore 854 recently funded biopharma companies with verified founder contact information and fundraising data.

Total Companies
854
Total Funding
$960.3M
Avg Funding
$38.4M
Global Reach
11
countries

Top Cities for Biopharma

South San Francisco
Boston
Wilmington
Milan
San Juan
Santiago De Compostela

Recently Funded Companies

Export
South San Francisco, United States

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

$150.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Boston, United States

Acta Pharmaceuticals is a pharmaceutical company.

$13.4M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Wilmington, United States

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.

$90.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Milan, Italy

Bio4Dreams is a privately funded certified incubator for innovative startups in very early stage phase, dedicated to Life Sciences.

$2.8M raised
Apr 2023

Founder Contacts

30,000+ verified contacts

South San Francisco, United States

Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.

$60.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

San Juan, Puerto Rico

Aspire Biopharma is a biotechnology company that develops nano technology drug formulation technology and medicinal products.

$22.5M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Santiago De Compostela, Spain

Addressing “undruggable intracellular targets” in oncology

Apr 2023

Founder Contacts

30,000+ verified contacts

Hamilton, Canada

Insight Medbotics is a health systems company that develops novel MRI-guided diagnostics.

$435K raised
Apr 2022

Founder Contacts

30,000+ verified contacts

Sacramento, United States

SaaS, Shape Analysis Software, Biotechnology, Healthcare, Clinical Decision Support

Apr 2022

Founder Contacts

30,000+ verified contacts

Adelaide, Australia

BiomeBank is a clinical stage biotechnology company developing microbial therapies

$10.8M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Dublin, Ireland

Juvenescence is a biotech company that develops therapies and products to modify aging and help people live longer.

$76.0M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Raleigh, United States

GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.

$2.5M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Cambridge, United States

Cullinan Therapeutics is a developer of an externally sourced cancer therapeutics used to end a drug program quickly.

$280.0M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Waltham, United States

Alloy Therapeutics is a biotechnology company that provides drug discovery services to support the development of therapeutic biologics.

$40.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Baltimore, United States

Aletira is an emerging biotechnology company based on technologies created at Johns Hopkins University.

$300K raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Tyler, United States

Pulmotherapeutics is a biotechnology company that offers pulmonary therapeutic sevices.

$500K raised
Apr 2025

Founder Contacts

30,000+ verified contacts

San Diego, United States

ImageneBio is dedicated to developing therapeutics for patients with immunological, autoimmune and inflammatory diseases

$30.0M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Basel, Switzerland

Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.

$50.0M raised
Apr 2022

Founder Contacts

30,000+ verified contacts

Ponte Vedra Beach, United States

Cadrenal Therapeutics develops a late-stage novel therapy for patients with end-stage renal disease and atrial fibrillation.

$2.5M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Ørsta, Norway

Arctic Bioscience is a biotech company that produces bioactive marine-based pharmaceutical and nutraceutical products and solutions.

$1.5M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Stans, Switzerland

NewcelX is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia.

$1.4M raised
Apr 2026

Founder Contacts

30,000+ verified contacts

Pallíni, Greece

Solmeyea produces single-cell proteins from CO2 for food applications, aiming at CO2 circularity and addressing climate issues.

$3.3M raised
Apr 2025

Founder Contacts

30,000+ verified contacts

Seattle, United States

Aurion Biotechnologies is a clinical-stage biotech company.

$120.0M raised
Apr 2022

Founder Contacts

30,000+ verified contacts

Warwick, United States

Adtech Pharma developed a novel formulation of a sole-sourced synthetic cannabinoid therapeutic targeting glaucoma.

$1.1M raised
Apr 2022

Founder Contacts

30,000+ verified contacts

Hong Kong, Hong Kong

Yuanbo Biotechnology is a provider of clever AI-driven cell manufacturing systems.

$1.3M raised
Apr 2024

Founder Contacts

30,000+ verified contacts

Showing 301 to 325 of 854 companies

About the Biopharma Startup Ecosystem

The biopharma sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.

Funding Trends in Biopharma

Biopharma companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.

Growth Outlook

The biopharma sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.

Biopharma Funding Breakdown

Here is how funding is distributed among the 854 biopharma companies tracked in the VCBacked database.

Average Funding
$38.4M
Total Funding Tracked
$960.3M
Countries Represented
11

Distribution by Funding Stage

Other25 companies

Top Cities for Biopharma

1.South San Francisco
2 companies$210.0M
2.Boston
1 companies$13.4M
3.Wilmington
1 companies$90.0M
4.Milan
1 companies$2.8M
5.San Juan
1 companies$22.5M

Related Industries

Companies in the biopharma sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.

Ready to Connect with Biopharma Startups?

Perfect for: B2B sales teams targeting biopharma companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked